{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:12:37Z","timestamp":1789985557768,"version":"4.0.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jid.2016.11.041","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T14:15:27Z","timestamp":1484662527000},"page":"1179-1181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Are Idiopathic Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis Related to Drugs in Food? The Example of Phenylbutazone"],"prefix":"10.1016","volume":"137","author":[{"given":"Cynthia","family":"Haddad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chosidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Valeyrie-Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Ghaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Legrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Barau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihel","family":"Khoudour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peggy","family":"Sekula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Hulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2016.11.041_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2885.2002.00421.x","article-title":"Pharmacodynamics and pharmacokinetics of phenylbutazone in calves","volume":"25","author":"Arifah","year":"2002","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.jid.2016.11.041_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2011.06.006","article-title":"Development and validation of a confirmatory method for the determination of 12 non-steroidal anti-inflammatory drugs in milk using liquid chromatography tandem mass spectrometry","volume":"1218","author":"Dubreil-Ch\u00e9neau","year":"2011","journal-title":"J\u00a0Chrom A"},{"key":"10.1016\/j.jid.2016.11.041_bib3","doi-asserted-by":"crossref","unstructured":"Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet, in press. ec.europa.eu\/food\/safety\/official_controls\/food_fraud\/horse_meat_en (accessed 2 February 2017).","DOI":"10.1016\/S0140-6736(16)30378-6"},{"key":"10.1016\/j.jid.2016.11.041_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00544025","article-title":"Diffusion of oxyphenbutazone into synovial fluid, synovial tissue, joint cartilage and cerebrospinal fluid","volume":"25","author":"Gaucher","year":"1983","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jid.2016.11.041_bib5","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/archderm.1987.01660330077013","article-title":"The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell\u2019s syndrome)","volume":"123","author":"Guillaume","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jid.2016.11.041_bib6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2885.1986.tb00031.x","article-title":"Phenylbutazone and oxyphenbutazone distribution into tissue fluids in the horse","volume":"9","author":"Lees","year":"1986","journal-title":"J\u00a0Vet Pharmacol Ther"},{"key":"10.1016\/j.jid.2016.11.041_bib7","first-page":"192","article-title":"Metabolism, excretion, pharmacokinetics and tissue residues of PBZ in the horse","volume":"77","author":"Lees","year":"1987","journal-title":"Cornell Veterinarian"},{"key":"10.1016\/j.jid.2016.11.041_bib8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tvjl.2013.04.019","article-title":"Pharmacokinetics, pharmacodynamics, metabolism, toxicology and residues of phenylbutazone in humans and horses","volume":"196","author":"Lees","year":"2013","journal-title":"Vet J"},{"key":"10.1016\/j.jid.2016.11.041_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.11.041_bib10","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2016.11.041_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson Syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jid.2016.11.041_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2016.11.041_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2885.1986.tb00008.x","article-title":"Phenylbutazone in the horse: a review","volume":"9","author":"Tobin","year":"1986","journal-title":"J\u00a0Vet Pharmacol Ther"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17300131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17300131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T13:23:32Z","timestamp":1568726612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X17300131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0022202X17300131"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2016.11.041","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are Idiopathic Stevens-Johnson Syndrome\/Toxic Epidermal Necrolysis Related to Drugs in Food? The Example of Phenylbutazone","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2016.11.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}